Home Physical Sciences 99mTc(I) carbonyl-radiolabeled lipid based drug carriers for temozolomide delivery and bioevaluation by in vitro and in vivo
Article
Licensed
Unlicensed Requires Authentication

99mTc(I) carbonyl-radiolabeled lipid based drug carriers for temozolomide delivery and bioevaluation by in vitro and in vivo

  • Kadir Arı , Eser Uçar , Çiğdem İçhedef , Ayfer Yurt Kılçar , Emin İlker Medine , Yasemin Parlak , Bedriye Elvan Sayıt Bilgin , Burcu Aydın , Fikriye Gül Gümüşer and Serap Teksöz EMAIL logo
Published/Copyright: March 15, 2019

Abstract

In preclinical research radiolabeled nanoparticles have been attracting interest as a new class of imaging probes. Assuming good stability of solid lipid nanoparticles (SLNs) under physiological conditions, radiolabeled SLNs can be used for imaging and measuring uptake in target tissue. Present study was performed to evaluate biological behavior of temozolomide (TMZ) loaded solid lipid nanoparticles (SLN-TMZ) in vivo and in vitro. Lipid nanoparticles were prepared by emulsification and low-temperature solidification method. ζ potential, morphology and particle size of nanoparticles were determined. Biological behavior of 99mTc(CO)3+ radiolabeled SLN-TMZ were investigated in vitro on U87/Daoy cell lines and in vivo on female Wistar Albino rats. Obtained results of in vitro incorporation, in vivo biodistribution and gamma imaging studies on radiolabeled SLN-TMZ show that the radiolabeled solid lipid nanoparticles could have potential as a drug delivery system for TMZ.


Corresponding author: Serap Teksöz, Department of Nuclear Applications, Institute of Nuclear Sciences Ege University, Bornova, 35100 İzmir, Turkey, Tel.: +90-232-3113466, Fax: +90-232-3886466

  1. Disclosure statement: This study was funded by The Scientific Technological Research Council of Turkey (TUBITAK, Project no: 113S369) and Ege University Science and Technology Centre (EBILTEM, Project no: 2014BIL035).

References

1. Kaur, I. P., Bhandari, R., Bhandari, S., Kakkar, V.: Potential of solid lipid nanoparticles in brain targeting. J. Control. Release. 127, 97 (2008).10.1016/j.jconrel.2007.12.018Search in Google Scholar PubMed

2. Qiao, R., Jia, Q., Hüwel, S., Xia, R., Liu, T., Gao, F., Galla, H.-J., Gao, M.: Receptor-Mediated Delivery of Magnetic Nanoparticles across the Blood–Brain Barrier. ACS Nano. 6, 3304 (2012).10.1021/nn300240pSearch in Google Scholar PubMed

3. Ucar, E., Teksoz, S., Ichedef, C., Kilcar, A. Y., Medine, E. I., Ari, K., Parlak, Y., Sayit Bilgin, B. E., Unak, P.: Synthesis, characterization and radiolabeling of folic acid modified nanostructured lipid carriers as a contrast agent and drug delivery system. Appl. Radiat. Isot. 119, 72 (2017).10.1016/j.apradiso.2016.11.002Search in Google Scholar PubMed

4. Wissing, S., Kayser, O., Müller, R.: Solid lipid nanoparticles for parenteral drug delivery. Adv. Drug Deliv. Rev. 56, 1257 (2004).10.1016/j.addr.2003.12.002Search in Google Scholar PubMed

5. Esteller, M.: Epigenetic lesions causing genetic lesions in human cancer: promoter hypermethylation of DNA repair genes. Eur. J. Cancer. 36, 2294 (2000).10.1016/S0959-8049(00)00303-8Search in Google Scholar PubMed

6. Huang, G., Zhang, N., Bi, X., Dou, M.: Solid lipid nanoparticles of temozolomide: potential reduction of cardial and nephric toxicity. Int. J. Pharm. 355, 314 (2008).10.1016/j.ijpharm.2007.12.013Search in Google Scholar PubMed

7. Laquintana, V., Trapani, A., Denora, N., Wang, F., Gallo, J. M., Trapani, G.: New strategies to deliver anticancer drugs to brain tumors. Expert Opin. Drug Deliv. 6, 1017 (2009).10.1517/17425240903167942Search in Google Scholar PubMed PubMed Central

8. Kreuter, J.: Nanoparticulate systems for brain delivery of drugs. Adv. Drug Deliv. Rev. 64, 213 (2001).10.1016/j.addr.2012.09.015Search in Google Scholar

9. Bondì, M. L., Craparo, E. F., Giammona, G., Drago, F.: Brain-targeted solid lipid nanoparticles containing riluzole: preparation, characterization and biodistribution. Nanomedicine 5, 25 (2010).10.2217/nnm.09.67Search in Google Scholar PubMed

10. Alberto, R., Schibli, R., Egli, A., Schubiger, A. P., Abram, U., Kaden, T. A.: A novel organometallic aqua complex of technetium for the labeling of biomolecules: synthesis of [99mTc(OH2)3(CO)3]+ from [99mTcO4]- in aqueous solution and its reaction with a bifunctional ligand. J. Am. Chem. Soc. 120, 7987 (1998).10.1021/ja980745tSearch in Google Scholar

11. Kim, H., Likhari, P., Parker, D., Statkevich, P., Marco, A., Lin, C. C., Nomeir, A. A.: High-performance liquid chromatographic analysis and stability of anti-tumor agent temozolomide in human plasma. J. Pharm. Biomed. Anal. 24, 461 (2001).10.1016/S0731-7085(00)00466-0Search in Google Scholar PubMed

12. Kovačević, A. B., Müller, R. H., Savić, S. D., Vuleta, G. M., Keck, C. M.: Solid lipid nanoparticles (SLN) stabilized with polyhydroxy surfactants: preparation, characterization and physical stability investigation. Colloids Surf. A Physicochem. Eng. Asp. 444, 15 (2014).10.1016/j.colsurfa.2013.12.023Search in Google Scholar

13. Venkateswarlu, V., Manjunath, K.: Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. J. Control. Release. 95, 627 (2004).10.1016/j.jconrel.2004.01.005Search in Google Scholar PubMed

14. Schubert, M. A., Müller-Goymann, C. C.: Characterisation of surface-modified solid lipid nanoparticles (SLN): influence of lecithin and nonionic emulsifier. Eur. J. Pharm. Biopharm. 61, 77 (2005).10.1016/j.ejpb.2005.03.006Search in Google Scholar PubMed

15. Zhou, H., Rao, J., Lin, J., Yin, B., Sheng, H., Lin, F., Zhang, N., Yang, L.: The insulin-like growth factor-I receptor kinase inhibitor NVP-ADW742 sensitizes medulloblastoma to the effects of chemotherapy. Oncol. Rep. 25, 1565 (2011).Search in Google Scholar PubMed

16. Ferretti, M., Fabbiano, C., Di Bari, M., Conte, C., Castigli, E., Sciaccaluga, M., Ponti, D., Ruggieri, P., Raco, A., Ricordy, R., Calogero, A., Tata, A. M.: M2 receptor activation inhibits cell cycle progression and survival in human glioblastoma cells. J. Cell. Mol. Med. 17, 552 (2013).10.1111/jcmm.12038Search in Google Scholar PubMed

17. Martins, S., Costa-Lima, S., Carneiro, T., Cordeiro-da-Silva, A., Souto, E. B., Ferreira, D. C.: Solid lipid nanoparticles as intracellular drug transporters: an investigation of the uptake mechanism and pathway. Int. J. Pharm. 430, 216 (2012).10.1016/j.ijpharm.2012.03.032Search in Google Scholar PubMed

18. Clemente, N., Ferrara, B., Gigliotti, C. L., Boggio, E., Capucchio, M. T., Biasibetti, E., Schiffer, D., Mellai, M., Annovazzi, L., Cangemi, L., Muntoni, E., Miglio, G., Dianzani, U., Battaglia, L., Dianzani, C.: Solid lipid nanoparticles carrying temozolomide for melanoma treatment. Preliminary in vitro and in vivo studies. Int. J. Mol. Sci. 19, 255 (2018).10.3390/ijms19020255Search in Google Scholar

19. Reddy, L. H., Sharma, R. K., Chuttani, K., Mishra, A. K., Murthy, R. S. R.: Influence of administration route on tumor uptake and biodistribution of etoposide loaded solid lipid nanoparticles in Dalton’s lymphoma tumor bearing mice. J. Control. Release 105, 185 (2005).10.1016/j.jconrel.2005.02.028Search in Google Scholar PubMed

20. Allen, T. M., Hansen, C. B., Guo, L. S. S.: Subcutaneous administration of liposomes: a comparison with the intravenous and intraperitoneal routes of injection. Biochim. Biophys. Acta 1150, 9 (1993).10.1016/0005-2736(93)90115-GSearch in Google Scholar PubMed

21. Khan, A., Khan, K., Imam, S. S., Aqil, M., Ahad, A., Sultana, Y., Ali, A.: Brain targeting of temozolomide via the intranasal route using lipid-based nanoparticles: brain pharmacokinetic and scintigraphic analyses. Mol. Pharm. 13, 3773 (2016).10.1021/acs.molpharmaceut.6b00586Search in Google Scholar PubMed

Received: 2018-07-13
Accepted: 2019-02-20
Published Online: 2019-03-15
Published in Print: 2019-11-26

©2019 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 13.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/ract-2018-3028/html
Scroll to top button